- Home
- ATOS vs STKS Comparison
ATOS vs STKS Comparison
Compare ATOS & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- STKS
- Stock Information
- Founded
- ATOS 2009
- STKS 2004
- Country
- ATOS United States
- STKS United States
- Employees
- ATOS N/A
- STKS N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- STKS Restaurants
- Sector
- ATOS Health Care
- STKS Consumer Discretionary
- Exchange
- ATOS Nasdaq
- STKS Nasdaq
- Market Cap
- ATOS 107.2M
- STKS 109.7M
- IPO Year
- ATOS 2012
- STKS N/A
- Fundamental
- Price
- ATOS $0.82
- STKS $2.96
- Analyst Decision
- ATOS Strong Buy
- STKS Hold
- Analyst Count
- ATOS 3
- STKS 3
- Target Price
- ATOS $6.17
- STKS $4.83
- AVG Volume (30 Days)
- ATOS 1.4M
- STKS 173.3K
- Earning Date
- ATOS 08-15-2025
- STKS 08-05-2025
- Dividend Yield
- ATOS N/A
- STKS N/A
- EPS Growth
- ATOS N/A
- STKS N/A
- EPS
- ATOS N/A
- STKS N/A
- Revenue
- ATOS N/A
- STKS $799,478,000.00
- Revenue This Year
- ATOS N/A
- STKS $27.38
- Revenue Next Year
- ATOS N/A
- STKS $5.75
- P/E Ratio
- ATOS N/A
- STKS N/A
- Revenue Growth
- ATOS N/A
- STKS 138.50
- 52 Week Low
- ATOS $0.55
- STKS $2.37
- 52 Week High
- ATOS $1.66
- STKS $5.26
- Technical
- Relative Strength Index (RSI)
- ATOS 44.93
- STKS 31.91
- Support Level
- ATOS $0.84
- STKS $3.23
- Resistance Level
- ATOS $0.98
- STKS $3.40
- Average True Range (ATR)
- ATOS 0.05
- STKS 0.23
- MACD
- ATOS -0.01
- STKS -0.11
- Stochastic Oscillator
- ATOS 7.65
- STKS 3.55
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.